Hydrix (ASX:HYD) share price soaring for the heavens with 54% gain

The Hydrix share price is soaring today after the company announced it has successfuly implanted its first patient in its access study.

soaring hydrix share price represented by doctor riding on top of heart high up in the clouds

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Hydrix Ltd (ASX: HYD) share price is soaring higher today after the company announced its 'AngelMed' platform has successfully carried out its first implant. At the time of writing, the Hydrix share price is trading 53.57% higher at 43 cents.

What Hydrix does

Hydrix is essentially a product innovation company. The company states its purpose as enhancing the health, safety, and wellbeing of one billion people. In order to do this, Hydrix leverages its product innovation capability across multiple growth platforms; services, ventures and medical.

The most notable of these platforms is Hydrix Medical. The medical platform aims to bring innovative medical technologies to market such as the implantable heart attack warning system driving the Hydrix share price today.

What happened?

The Hydrix share price took off again after the medical product innovation company released an announcement to the ASX today. The announcement was regarding the company's AngelMed System that can be used to prevent silent heart attacks.

It was announced that a patient had received the first implant of the AngelMed Guardian System as part of the ALERTS continued access study.

The United States Food and Drug Administration (FDA) granted Hydrix approval to re-implant 260 clinical trial patients under its continued access study. The objective of the ALERTS continued access study is to provide its former clinical trial patients access to the next generation device and its life-saving features. 

Earlier in the year, the initial supply of the device caused the Hydrix share price to jump 250%.

Groundbreaking technology driving the Hydrix share price

As discussed briefly above, the AngelMed Guardian system is designed to track significant changes in the heart's electrical signals, which includes detection of silent heart attacks, and then alert patients to seek medical attention. It is an implantable cardiac monitor with patient alerting for patients who have had prior acute coronary syndromes, or other heart related diseases.

Hydrix's device has received high praise from the medical community, with the implanting surgeon, Kelly Tucker, M.D., stating:

The AngelMed Guardian represents a real game changer in the management of coronary artery disease. This is the first ever surveillance tool for patients with a prior coronary event and has the potential to save countless lives and bring peace of mind to thousands of families. It is a great honour to be involved in this amazing technology.

With today's gain, the Hydrix share price is now up 95% so far this year.

Should you invest $1,000 in National Australia Bank Limited right now?

Before you buy National Australia Bank Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and National Australia Bank Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A corporate man crosses his arms to make an X, indicating no deal.
Opinions

How to invest: my 3 biggest ASX share dealbreakers

I want to avoid certain things with my investing.

Read more »

hands holding up winners cup, asx 200 winning shares
Share Market News

Guess which stock just became the world's most valuable company?

There's a new sheriff (back) in town.

Read more »

Happy man working on his laptop.
Share Market News

5 things to watch on the ASX 200 on Monday

The local market looks set to have a positive start to the week.

Read more »

a woman holds her hands up in delight as she sits in front of her lap
Share Market News

US jobs report ignites market rally. What could move the needle this week?

All eyes on the Federal Reserve.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Opinions

Why I think these 2 ASX shares are bargain buys

I like the value offered by these stocks.

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Opinions

My favourite ASX 200 stock in my portfolio right now

This business has a lot going for it, in my opinion.

Read more »

Woman smiling in a warehouse.
Share Market News

Post merger, what's Macquarie's price target on Amcor shares?

What could this merger mean for Amcor shares?

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in May

The broker is feeling bullish on these names this month. Let's find out why.

Read more »